Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.10.2 extracted from

  • Myers, S.; Temps, C.; Houston, D.; Brunton, V.; Unciti-Broceta, A.
    Development of potent inhibitors of receptor tyrosine kinases by ligand-based drug design and target-biased phenotypic screening (2018), J. Med. Chem., 61, 2104-2110 .
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
BGB324 i.e. Bemcentinib Homo sapiens
additional information development of potent inhibitors of receptor tyrosine kinases by ligand-based drug design and target-biased phenotypic screening Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P12931
-
-

Synonyms

Synonyms Comment Organism
Src kinase
-
Homo sapiens

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.000037
-
pH and temperature not specified in the publication Homo sapiens BGB324